Yigal M. Pinto

29.5k citations

218 papers · 15.9k indexed · 5 hit papers · h-index 67

Cardiology and Cardiovascular Medicine top 0.1%
Molecular Biology top 0.5%
Cancer Research top 0.2%
Surgery top 2%
Immunology top 2%

Co-authors: Esther E. Creemers Anke J. Tijsen Harry J.G.M. Crijns James L. Januzzi Antoni Bayés‐Genís Blanche Schroen León J. De Windt Mark Richards
Topics: Heart Failure Treatment and Management (53 papers)Cardiomyopathy and Myosin Studies (43 papers)Cardiovascular Effects of Exercise (31 papers)
Cited by: Cardiology and Cardiovascular Medicine Cancer Research Molecular Biology
Journals: Proceedings of the National Academy of Sciences The Lancet Journal of Biological Chemistry
Partner nations: Netherlands United States Germany

In The Last Decade

Yigal M. Pinto

213 papers receiving 15.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating MicroRNAs

2012 824 citations Esther E. Creemers, Anke J. Tijsen et al. profile →
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients

2005 821 citations James L. Januzzi, Antoni Bayés‐Genís et al. European Heart Journal profile →
Galectin-3 Marks Activated Macrophages in Failure-Prone Hypertrophied Hearts and Contributes to Cardiac Dysfunction

2004 735 citations Jop H. van Berlo, Jack P.M. Cleutjens et al. Circulation profile →
miR-133 and miR-30 Regulate Connective Tissue Growth Factor

2008 700 citations Rudy F. Duisters, Anke J. Tijsen et al. profile →
MiR423-5p As a Circulating Biomarker for Heart Failure

2010 530 citations Anke J. Tijsen, Esther E. Creemers et al. profile →

Peers

Countries citing papers authored by Yigal M. Pinto

Since Specialization

Citations

This map shows the geographic impact of Yigal M. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yigal M. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yigal M. Pinto more than expected).

Fields of papers citing papers by Yigal M. Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yigal M. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yigal M. Pinto. The network helps show where Yigal M. Pinto may publish in the future.

Co-authorship network of co-authors of Yigal M. Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Yigal M. Pinto. A scholar is included among the top collaborators of Yigal M. Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yigal M. Pinto. Yigal M. Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polygenic Risk Scores in Dilated Cardiomyopathy: Towards the Future 2025 ·Current Cardiology Reports ·(unknown),Sean J. Jurgens,Yigal M. Pinto,Connie R. Bezzina,Ahmad S. Amin	1
2	Cardiac Ventricular Hinge Point LGE Is Highly Prevalent and Sex-Dependent in ELITE Athletes 2025 ·Circulation Cardiovascular Imaging ·(unknown),(unknown),(unknown),S. Matthijs Boekholdt,R. Nils Planken,Maarten Groenink,Adriënne van Randen,(unknown),(unknown),Maarten H. Moen,Birgitta K. Velthuis,Yigal M. Pinto,(unknown),Niek H. J. Prakken,H T Jørstad	0
3	Long-term cardiac follow-up of athletes infected with SARS-CoV-2 after resumption of elite-level sports 2023 ·Heart ·(unknown),(unknown),(unknown),(unknown),(unknown),Maarten Groenink,S. Matthijs Boekholdt,R. Nils Planken,Adriënne van Randen,Alexander Hirsch,Maarten H. Moen,Yigal M. Pinto,Arthur A.M. Wilde,H T Jørstad	1
4	Quaking regulates circular RNA production in cardiomyocytes 2023 ·Journal of Cell Science ·(unknown),Ingeborg van der Made,Simona Aufiero,Anke J. Tijsen,Yigal M. Pinto,Esther E. Creemers	14
5	The RNA-binding protein QKI governs a muscle-specific alternative splicing program that shapes the contractile function of cardiomyocytes 2023 ·Cardiovascular Research ·(unknown),Simona Aufiero,(unknown),Ingeborg van der Made,(unknown),(unknown),Stéphane Richard,Diederik W.D. Kuster,Vincent M. Christoffels,Yigal M. Pinto,Esther E. Creemers	28
6	Evaluation of a New Aptamer-Based Array for Soluble Suppressor of Tumorgenicity (ST2) and N-terminal Pro-B-Type Natriuretic Peptide (NTproBNP) in Heart Failure Patients 2023 ·Journal of Cardiovascular Translational Research ·(unknown),Bashar Hannawi,Edward L. Peterson,Hongsheng Gui,(unknown),Jasmine A. Luzum,Hani N. Sabbah,James Snider,Yigal M. Pinto,L. Keoki Williams,David E. Lanfear	1
7	shRNAs Targeting a Common KCNQ1 Variant Could Alleviate Long-QT1 Disease Severity by Inhibiting a Mutant Allele 2022 ·International Journal of Molecular Sciences ·(unknown),Ronald Wilders,(unknown),(unknown),Irit Huber,Ingeborg van der Made,Anouk van den Bout,(unknown),Lior Gepstein,Arie O. Verkerk,Yigal M. Pinto,Anke J. Tijsen	5
8	Case report: the role of multimodal imaging to optimize the timing of return to sports in an elite athlete with persistent COVID-19 myocardial inflammation 2022 ·European Heart Journal - Case Reports ·(unknown),(unknown),Yigal M. Pinto,H T Jørstad	4
9	Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction 2021 ·Circulation Genomic and Precision Medicine ·Hongsheng Gui,Ruicong She,Jasmine A. Luzum,Jia Li,(unknown),Yigal M. Pinto,Hani N. Sabbah,L. Keoki Williams,David E. Lanfear	16
10	The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin–angiotensin system 2020 ·European Heart Journal - Cardiovascular Pharmacotherapy ·(unknown),R.C. Montijn,Sandeep Singh,Martin Paul,Yigal M. Pinto,Sara‐Joan Pinto‐Sietsma	39
11	NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure 2017 ·Circulation ·Susan Stienen,Khibar Salah,Arno H. Moons,(unknown),(unknown),(unknown),João Pedro Ferreira,Irene Marques,Jutta M. Schroeder‐Tanka,J. Keijer,Antoni Bayés‐Genís,Jan G.P. Tijssen,Yigal M. Pinto,Wouter E.M. Kok	101
12	Prognostic Value of Circulating microRNAs on Heart Failure-Related Morbidity and Mortality in Two Large Diverse Cohorts of General Heart Failure Patients 2017 ·European Journal of Heart Failure ·Antoni Bayés‐Genís,David E. Lanfear,Maurice W.J. de Ronde,Josep Lupón,Joost J. Leenders,Zhen Liu,Nicolaas P. A. Zuithoff,Marinus J.C. Eijkemans,Elisabet Zamora,Marta de Antonio,Aeilko H. Zwinderman,Sara‐Joan Pinto‐Sietsma,Yigal M. Pinto	66
13	Truncating Titin Mutations are Associated with a Mild and Treatable form of Dilated Cardiomyopathy 2016 ·European Journal of Heart Failure ·Joeri A. Jansweijer,(unknown),Francesco Paolo Russo,Edgar T. Hoorntje,Jan D.H. Jongbloed,Ronald H. Lekanne Deprez,Alex V. Postma,Marieke Bronk,Ingrid A.W. van Rijsingen,Simone de Haij,Elena Biagini,Paul L. van Haelst,Jan van Wijngaarden,Maarten P. van den Berg,Arthur A.M. Wilde,Marcel M. A. M. Mannens,Rudolf A. de Boer,Karin Y. van Spaendonck‐Zwarts,J. Peter van Tintelen,Yigal M. Pinto	108
14	Which Heart Failure Patients Profit from Natriuretic Peptide Guided Therapy? a Meta-Analysis from Individual Patient Data of Randomized Trials 2015 ·European Journal of Heart Failure ·Hans‐Peter Brunner‐La Rocca,Luc W.M. Eurlings,Mark Richards,James L. Januzzi,Matthias Pfisterer,Ulf Dahlström,Yigal M. Pinto,Patric Karlström,(unknown),Rudolf Berger,Hans Persson,Christopher M. O’Connor,Deddo Moertl,Hanna K. Gaggin,Christopher Frampton,M. Gary Nicholls,Richard W. Troughton	67
15	Challenging the Two Concepts in Determining the Appropriate Pre-Discharge N-Terminal Pro-Brain Natriuretic Peptide Treatment Target in Acute Decompensated Heart Failure Patients: Absolute or Relative Discharge Levels? 2015 ·European Journal of Heart Failure ·Susan Stienen,Khibar Salah,Luc W.M. Eurlings,Paulo Bettencourt,Joana Pimenta,Marco Metra,Antoni Bayés‐Genís,Valerio Verdiani,Luca Bettari,Valentina Lazzarini,Jan Tijssen,Yigal M. Pinto,Wouter E.M. Kok	26
16	A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score 2013 ·Heart ·Khibar Salah,Wouter E.M. Kok,Luc W.M. Eurlings,Paulo Bettencourt,Joana Pimenta,Marco Metra,Antoni Bayés‐Genís,Valerio Verdiani,Luca Bettari,Valentina Lazzarini,Peter Damman,Jan G.P. Tijssen,Yigal M. Pinto	95
17	Genetic Analysis in 418 Index Patients with Idiopathic Dilated Cardiomyopathy: Overview of 10 Years’ Experience 2013 ·European Journal of Heart Failure ·Karin Y. van Spaendonck‐Zwarts,Ingrid A.W. van Rijsingen,Maarten P. van den Berg,Ronald H. Lekanne Deprez,Jan G. Post,Anneke M. van Mil,Folkert W. Asselbergs,Imke Christiaans,Irene M. van Langen,Arthur A.M. Wilde,Rudolf A. de Boer,Jan D.H. Jongbloed,Yigal M. Pinto,J. Peter van Tintelen	114
18	Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner 2011 ·European Heart Journal ·Ahmad S. Amin,John R. Giudicessi,Anke J. Tijsen,Anne M. Spanjaart,Yolan J. Reckman,Christine A. Klemens,Michael W.T. Tanck,Jamie D. Kapplinger,Nynke Hofman,Moritz F. Sinner,Martina Müller‐Nurasyid,Wino J. Wijnen,Hanno L. Tan,Connie R. Bezzina,Esther E. Creemers,Arthur A.M. Wilde,Michael J. Ackerman,Yigal M. Pinto	94
19	Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction 2008 ·The Journal of Experimental Medicine ·Mark W.M. Schellings,Davy Vanhoutte,Melissa Swinnen,Jack P.M. Cleutjens,Jacques Debets,Rick E.W. van Leeuwen,Jan D’hooge,Frans Van de Werf,Peter Carmeliet,Yigal M. Pinto,E. Helene Sage,Stéphane Heymans	166
20	A-type lamins are essential for TGF-β1 induced PP2A to dephosphorylate transcription factors 2005 ·Human Molecular Genetics ·Jop H. van Berlo,Jan Willem Voncken,Nard Kubben,Jos L. V. Broers,Rudy F. Duisters,Rick E.W. van Leeuwen,Harry J.G.M. Crijns,Frans C. S. Ramaekers,Christopher J. Hutchison,Yigal M. Pinto	129

About Yigal M. Pinto

Yigal M. Pinto is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology, having authored 218 papers that have together received 15.9k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (53 papers), Cardiomyopathy and Myosin Studies (43 papers) and Cardiovascular Effects of Exercise (31 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.9k citations), Cancer Research (3.2k citations) and Molecular Biology (7.2k citations). Yigal M. Pinto has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Esther E. Creemers, Anke J. Tijsen, Harry J.G.M. Crijns, James L. Januzzi, Antoni Bayés‐Genís, Blanche Schroen, León J. De Windt, Mark Richards, Umesh C. Sharma and Stéphane Heymans. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact